{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:57:27Z","timestamp":1790751447417,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Canine babesiosis is a tick-borne disease of significant veterinary importance in dogs. It is caused by\n                      <jats:italic>Babesia canis<\/jats:italic>\n                      in Europe, where it is transmitted by\n                      <jats:italic>Dermacentor reticulatus<\/jats:italic>\n                      ticks.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A blinded, randomized, good clinical practice (GCP) and negative control experimental study was conducted to verify the efficacy of NexGard Spectra\u00ae in reducing the transmission of\n                      <jats:italic>B.\u00a0canis<\/jats:italic>\n                      by\n                      <jats:italic>D.\u00a0reticulatus<\/jats:italic>\n                      to dogs. NexGard Spectra\u00ae (IVP) is an oral product for dogs combining afoxolaner, an acaricide\/insecticide compound from the isoxazoline class, and milbemycin oxime, a nematicide compound from the macrocyclic lactone class. Three groups of eight dogs were used; one group orally treated on day 0 with the IVP at the minimum recommended dose and two untreated control groups. On day 1, dogs from the treated group and from control group 1 were infested with 50\n                      <jats:italic>D.\u00a0reticulatus<\/jats:italic>\n                      adult ticks of 50\/50 sex ratio infected with\n                      <jats:italic>B.\u00a0canis<\/jats:italic>\n                      at a 23% infection rate. On day 28, dogs from the treated group and from control group 2 were infested similarly to those on day 1. Ticks were removed 6\u00a0days after each infestation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven to nine days after each infestation, all untreated control dogs displayed clinical signs of canine babesiosis, i.e., lethargy, and\/or dark urine, and\/or &gt;\u200939.5\u00a0\u00b0C rectal temperature. Blood was collected for microscopical blood smear examination, and for polymerase chain reaction (PCR) analysis. The blood smears from all untreated control dogs were positive for\n                      <jats:italic>Babesia<\/jats:italic>\n                      and all the PCR analyses were positive for\n                      <jats:italic>B.\u00a0canis.<\/jats:italic>\n                      The control dogs were rescue treated. All control dogs were confirmed positive for\n                      <jats:italic>B.\u00a0canis<\/jats:italic>\n                      by IFA on day 21 (control group 1) and on day 42 (control group 2). None of the IVP-treated dogs expressed any clinical sign of canine babesiosis following each of the two infestations of days 1 and 28 and until day 56. Blood was collected for IFA and PCR analyses from the treated dogs on days 21, 28, 42, and 56, and all results were negative.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In this study, the antiparasitic treatment prevented the transmission of\n                      <jats:italic>B.\u00a0canis<\/jats:italic>\n                      to dogs following induced infestations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-025-06787-y","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:31:16Z","timestamp":1744716676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of an oral combination of afoxolaner and milbemycin oxime for the prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs"],"prefix":"10.1186","volume":"18","author":[{"given":"Eric","family":"Tielemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin","family":"Rautenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alta","family":"Viljoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Beugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"6787_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12941-017-0179-z","volume":"16","author":"T Akel","year":"2017","unstructured":"Akel T, Mobarakai N. Hematologic manifestations of babesiosis. Ann Clin Microbiol Antimicrob. 2017;16:6. https:\/\/doi.org\/10.1186\/s12941-017-0179-z.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"6787_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.ijpara.2008.03.001","volume":"38","author":"KP Hunfeld","year":"2008","unstructured":"Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol. 2008;38:1219\u201337. https:\/\/doi.org\/10.1016\/j.ijpara.2008.03.001.","journal-title":"Int J Parasitol"},{"key":"6787_CR3","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.3390\/ijerph20126156","volume":"20","author":"SA Malgwi","year":"2023","unstructured":"Malgwi SA, Ogunsakin RE, Oladepo AD, Adeleke MA, Okpeku M. A forty-year analysis of the literature on Babesia infection (1982\u20132022): a systematic bibliometric approach. Int J Environ Res Public Health. 2023;20:6156. https:\/\/doi.org\/10.3390\/ijerph20126156.","journal-title":"Int J Environ Res Public Health"},{"key":"6787_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.vetpar.2006.01.035","volume":"138","author":"G Uilenberg","year":"2006","unstructured":"Uilenberg G. Babesia\u2013a historical overview. Vet Parasitol. 2006;138:3\u201310. https:\/\/doi.org\/10.1016\/j.vetpar.2006.01.035.\u00a0","journal-title":"Vet Parasitol"},{"key":"6787_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.idc.2015.02.008","volume":"29","author":"EG Vannier","year":"2015","unstructured":"Vannier EG, Diuk-Wasser MA, Ben Mamoun C, Krause PJ. Babesiosis. Infect Dis Clin North Am. 2015;29:357\u201370. https:\/\/doi.org\/10.1016\/j.idc.2015.02.008.","journal-title":"Infect Dis Clin North Am"},{"key":"6787_CR6","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.meegid.2012.07.004","volume":"12","author":"L Schnittger","year":"2012","unstructured":"Schnittger L, Rodriguez AE, Florin-Christensen M, Morrison DA. Babesia: a world emerging. Infect Genet Evol. 2012;12:1788\u2013809. https:\/\/doi.org\/10.1016\/j.meegid.2012.07.004.","journal-title":"Infect Genet Evol"},{"key":"6787_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.cvsm.2022.07.016","volume":"52","author":"JD Dear","year":"2022","unstructured":"Dear JD, Birkenheuer A. Babesia in North America: an update. Vet Clin North Am Small Anim Pract. 2022;52:1193\u2013209. https:\/\/doi.org\/10.1016\/j.cvsm.2022.07.016.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"6787_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/pathogens12121437","volume":"12","author":"AL Leisewitz","year":"2023","unstructured":"Leisewitz AL, Mrljak V, Dear JD, Birkenheuer A. The diverse pathogenicity of various Babesia parasite species that infect dogs. Pathogens. 2023;12:1437. https:\/\/doi.org\/10.3390\/pathogens12121437.","journal-title":"Pathogens"},{"key":"6787_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13071-016-1596-0","volume":"9","author":"L Solano-Gallego","year":"2016","unstructured":"Solano-Gallego L, Sainz \u00c1, Roura X, Estrada-Pe\u00f1a A, Mir\u00f3 G. A review of canine babesiosis: the European perspective. Parasit Vectors. 2016;9:336. https:\/\/doi.org\/10.1186\/s13071-016-1596-0.","journal-title":"Parasit Vectors"},{"key":"6787_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/jvim.13822","volume":"30","author":"RM Eichenberger","year":"2016","unstructured":"Eichenberger RM, Riond B, Willi B, Hofmann-Lehmann R, Deplazes P. Prognostic markers in acute Babesia canis infections. J Vet Intern Med. 2016;30:174\u201382. https:\/\/doi.org\/10.1111\/jvim.13822. (Epub 2016 Jan 4).","journal-title":"J Vet Intern Med"},{"key":"6787_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.vetpar.2018.03.001","volume":"254","author":"G Baneth","year":"2018","unstructured":"Baneth G. Antiprotozoal treatment of canine babesiosis. Vet Parasitol. 2018;254:58\u201363. https:\/\/doi.org\/10.1016\/j.vetpar.2018.03.001.\u00a0","journal-title":"Vet Parasitol"},{"key":"6787_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.20506\/rst.34.2.2385","volume":"34","author":"F Beugnet","year":"2015","unstructured":"Beugnet F, Moreau Y. Babesiosis. Rev Sci Tech. 2015;34:627\u201339. https:\/\/doi.org\/10.20506\/rst.34.2.2385.","journal-title":"Rev Sci Tech"},{"key":"6787_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/1756-3305-7-283","volume":"7","author":"F Beugnet","year":"2014","unstructured":"Beugnet F, Halos L, Larsen D, Labuschagn\u00e9 M, Erasmus H, Fourie J. The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs. Parasit Vectors. 2014;7:283. https:\/\/doi.org\/10.1186\/1756-3305-7-283.","journal-title":"Parasit Vectors"},{"key":"6787_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2021.109369","volume":"290","author":"D Otranto","year":"2021","unstructured":"Otranto D, Dantas-Torres F, Fourie JJ, Lorusso V, Varloud M, Gradoni L, et\u00a0al. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for studies evaluating the efficacy of parasiticides in reducing the risk of vector-borne pathogen transmission in dogs and cats. Vet Parasitol. 2021;290:109369. https:\/\/doi.org\/10.1016\/j.vetpar.2021.109369.\u00a0","journal-title":"Vet Parasitol"},{"key":"6787_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/vbz.2016.1955","volume":"17","author":"L Lempereur","year":"2017","unstructured":"Lempereur L, Beck R, Fonseca I, Marques C, Duarte A, Santos M, et\u00a0al. Guidelines for the detection of Babesia and Theileria Parasites. Vector Borne Zoonotic Dis. 2017;17:51\u201365. https:\/\/doi.org\/10.1089\/vbz.2016.1955.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"6787_CR16","doi-asserted-by":"publisher","unstructured":"Troskie M, de Villiers L, Leisewitz A, Oosthuizen MC, Quan M. Development and validation of a multiplex, real-time PCR assay for Babesia rossi and Babesia vogeli. Ticks Tick Borne Dis. 2019;10:421\u201332. https:\/\/doi.org\/10.1016\/j.ttbdis.2018.12.004.\u00a0","DOI":"10.1016\/j.ttbdis.2018.12.004"},{"key":"6787_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s13071-021-05014-8","volume":"14","author":"D Heylen","year":"2021","unstructured":"Heylen D, Day M, Schunack B, Fourie J, Labuschange M, Johnson S, et\u00a0al. A community approach of pathogens and their arthropod vectors (ticks and fleas) in dogs of African Sub-Sahara. Parasit Vectors. 2021;14:576. https:\/\/doi.org\/10.1186\/s13071-021-05014-8.","journal-title":"Parasit Vectors"},{"key":"6787_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13071-016-1599-x","volume":"9","author":"G F\u00f6ldv\u00e1ri","year":"2016","unstructured":"F\u00f6ldv\u00e1ri G, \u0160irok\u00fd P, Szekeres S, Majoros G, Sprong H. Dermacentor reticulatus: a vector on the rise. Parasit Vectors. 2016;9:314. https:\/\/doi.org\/10.1186\/s13071-016-1599-x.","journal-title":"Parasit Vectors"},{"key":"6787_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00574-22","volume":"66","author":"S Ji","year":"2022","unstructured":"Ji S, Galon EM, Rizk MA, Yi Y, Zafar I, Li H, et\u00a0al. Efficacy of the antimalarial MMV390048 against Babesia infection reveals phosphatidylinositol 4-kinase as a druggable target for babesiosis. Antimicrob Agents Chemother. 2022;66:e0057422. https:\/\/doi.org\/10.1128\/aac.00574-22.\u00a0","journal-title":"Antimicrob Agents Chemother"},{"key":"6787_CR20","doi-asserted-by":"publisher","first-page":"102315","DOI":"10.1016\/j.ttbdis.2024.102315","volume":"15","author":"C Weingart","year":"2024","unstructured":"Weingart C, Kr\u00fccken J, Kohn B. Repeated imidocarb treatment failure suggesting emerging resistance of Babesia canis in a new endemic area in north-eastern Germany. Ticks Tick Borne Dis. 2024;15:102315\u20136. https:\/\/doi.org\/10.1016\/j.ttbdis.2024.102315.","journal-title":"Ticks Tick Borne Dis"},{"key":"6787_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.intimp.2014.05.027","volume":"21","author":"S Kuriakose","year":"2014","unstructured":"Kuriakose S, Uzonna JE. Diminazene aceturate (Berenil), a new use for an old compound? Int Immunopharmacol. 2014;21:342\u20135. https:\/\/doi.org\/10.1016\/j.intimp.2014.05.027.\u00a0","journal-title":"Int Immunopharmacol"},{"key":"6787_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1365-3024.1995.tb00891.x","volume":"17","author":"TH Schetters","year":"1995","unstructured":"Schetters TH, Kleuskens J, Scholtes N, Bos HJ. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens. Parasite Immunol. 1995;17:215\u20138. https:\/\/doi.org\/10.1111\/j.1365-3024.1995.tb00891.x.","journal-title":"Parasite Immunol"},{"key":"6787_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.vetpar.2017.11.002","volume":"249","author":"K Moubri","year":"2018","unstructured":"Moubri K, Kleuskens J, Van de Crommert J, Scholtes N, Van Kasteren T, Delbecq S, et\u00a0al. Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection. Vet Parasitol. 2018;249:21\u20139. https:\/\/doi.org\/10.1016\/j.vetpar.2017.11.002.\u00a0","journal-title":"Vet Parasitol"},{"key":"6787_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijpara.2018.12.002","volume":"49","author":"S Nathaly Wieser","year":"2019","unstructured":"Nathaly Wieser S, Schnittger L, Florin-Christensen M, Delbecq S, Schetters T. Vaccination against babesiosis using recombinant GPI-anchored proteins. Int J Parasitol. 2019;49:175\u201381. https:\/\/doi.org\/10.1016\/j.ijpara.2018.12.002.\u00a0","journal-title":"Int J Parasitol"},{"key":"6787_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13071-019-3393-z","volume":"12","author":"JJ Fourie","year":"2019","unstructured":"Fourie JJ, de Vos C, Crafford D, Pollmeier M, Schunack B. A study on the long-term efficacy of Seresto\u00ae collars in preventing Babesia canis (Piana & Galli-Valerio, 1895) transmission to dogs by infected Dermacentor reticulatus (Fabricius, 1794) ticks. Parasit Vectors. 2019;12:139. https:\/\/doi.org\/10.1186\/s13071-019-3393-z.","journal-title":"Parasit Vectors"},{"key":"6787_CR26","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1186\/s13071-015-1207-5","volume":"8","author":"F Jongejan","year":"2015","unstructured":"Jongejan F, de Vos C, Fourie JJ, Beugnet F. A novel combination of fipronil and permethrin (Frontline Tri-Act\u00ae\/Frontect\u00ae) reduces risk of transmission of Babesia canis by Dermacentor reticulatus and of Ehrlichia canis by Rhipicephalus sanguineus ticks to dogs. Parasit Vectors. 2015;8:602. https:\/\/doi.org\/10.1186\/s13071-015-1207-5.","journal-title":"Parasit Vectors"},{"key":"6787_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13071-015-0645-4","volume":"8","author":"C Navarro","year":"2015","unstructured":"Navarro C, Reymond N, Fourie J, Hellmann K, Bonneau S. Prevention of Babesia canis in dogs: efficacy of a fixed combination of permethrin and fipronil (Effitix\u00ae) using an experimental transmission blocking model with infected Dermacentor reticulatus ticks. Parasit Vectors. 2015;8:32. https:\/\/doi.org\/10.1186\/s13071-015-0645-4.","journal-title":"Parasit Vectors"},{"key":"6787_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.vetpar.2010.05.017","volume":"172","author":"D Otranto","year":"2010","unstructured":"Otranto D, de Caprariis D, Lia RP, Tarallo V, Lorusso V, Testini G, et\u00a0al. Prevention of endemic canine vector-borne diseases using imidacloprid 10% and permethrin 50% in young dogs: a longitudinal field study. Vet Parasitol. 2010;172:323\u201332. https:\/\/doi.org\/10.1016\/j.vetpar.2010.05.017.\u00a0","journal-title":"Vet Parasitol"},{"key":"6787_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cimid.2016.09.004","volume":"49","author":"CF Baker","year":"2016","unstructured":"Baker CF, McCall JW, McCall SD, Drag MD, Mitchell EB, Chester ST, et\u00a0al. Ability of an oral formulation of afoxolaner to protect dogs from Borrelia burgdorferi infection transmitted by wild Ixodes scapularis ticks. Comp Immunol Microbiol Infect Dis. 2016;49:65\u20139. https:\/\/doi.org\/10.1016\/j.cimid.2016.09.004.\u00a0","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"6787_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s13071-017-2473-1","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. Two randomized, controlled studies to assess the efficacy and safety of lotilaner (Credelio\u2122) in preventing Dermacentor reticulatus transmission of Babesia canis to dogs. Parasit Vectors. 2017;10:520. https:\/\/doi.org\/10.1186\/s13071-017-2473-1.","journal-title":"Parasit Vectors"},{"key":"6787_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s13071-017-2358-3","volume":"10","author":"T Geurden","year":"2017","unstructured":"Geurden T, Six R, Becskei C, Maeder S, Lloyd A, Mahabir S, et\u00a0al. Evaluation of the efficacy of sarolaner (Simparica\u00ae) in the prevention of babesiosis in dogs. Parasit Vectors. 2017;10:415. https:\/\/doi.org\/10.1186\/s13071-017-2358-3.","journal-title":"Parasit Vectors"},{"key":"6787_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.pt.2024.04.009","volume":"40","author":"D Otranto","year":"2024","unstructured":"Otranto D, Mendoza-Roldan JA, Beugnet F, Baneth G, Dantas-Torres F. New paradigms in the prevention of canine vector-borne diseases. Trends Parasitol. 2024;40:500\u201310. https:\/\/doi.org\/10.1016\/j.pt.2024.04.009.\u00a0","journal-title":"Trends Parasitol"},{"key":"6787_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13071-015-0923-1","volume":"8","author":"J Taenzler","year":"2015","unstructured":"Taenzler J, Liebenberg J, Roepke RK, Heckeroth AR. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto\u2122). Parasit Vectors. 2015;8:305. https:\/\/doi.org\/10.1186\/s13071-015-0923-1.","journal-title":"Parasit Vectors"},{"key":"6787_CR34","doi-asserted-by":"publisher","first-page":"742","DOI":"10.4269\/ajtmh.1980.29.742","volume":"29","author":"J Piesman","year":"1980","unstructured":"Piesman J, Spielman A. Human babesiosis on Nantucket Island: prevalence of Babesia microti in ticks. Am J Trop Med Hyg. 1980;29:742\u20136. https:\/\/doi.org\/10.4269\/ajtmh.1980.29.742.","journal-title":"Am J Trop Med Hyg"},{"key":"6787_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1749-6632.1992.tb19628.x","volume":"653","author":"JL Hodgson","year":"1992","unstructured":"Hodgson JL. Biology and transmission of Babesia bigemina in Boophilus microplus. Ann N Y Acad Sci. 1992;653:42\u201351. https:\/\/doi.org\/10.1111\/j.1749-6632.1992.tb19628.x.","journal-title":"Ann N Y Acad Sci"},{"key":"6787_CR36","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00436-016-4924-6","volume":"115","author":"S Rehbein","year":"2016","unstructured":"Rehbein S, Fourie JJ, de Vos C, Anderson A, Larsen DL, Jeannin P. Efficacy of oral afoxolaner plus milbemycin oxime chewables against induced infestations with Dermacentor reticulatus in dogs. Parasitol Res. 2016;115:1845\u201351. https:\/\/doi.org\/10.1007\/s00436-016-4924-6.\u00a0","journal-title":"Parasitol Res"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06787-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06787-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06787-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:31:17Z","timestamp":1744716677000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06787-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6787"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06787-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5796842\/v1","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"E.T. and F.B. are employees of Boehringer Ingelheim Animal Health, manufacturer of the investigated product (NexGard Spectra\u00ae) and sponsor of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Animals were managed with due regard for their well-being, and the Institutional Animal Care and Use Committee reviewed and approved the study design.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"142"}}